1. Home
  2. QH vs ADIL Comparison

QH vs ADIL Comparison

Compare QH & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QH

Quhuo Limited American Depository Shares

HOLD

Current Price

$3.35

Market Cap

10.1M

ML Signal

HOLD

Logo Adial Pharmaceuticals Inc

ADIL

Adial Pharmaceuticals Inc

N/A

Current Price

$3.49

Market Cap

11.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
QH
ADIL
Founded
2012
2010
Country
China
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1M
11.4M
IPO Year
2019
2017

Fundamental Metrics

Financial Performance
Metric
QH
ADIL
Price
$3.35
$3.49
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
★ $8.33
AVG Volume (30 Days)
10.3K
★ 38.3K
Earning Date
10-27-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$2.86
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.07
$0.13
52 Week High
$12.81
$9.75

Technical Indicators

Market Signals
Indicator
QH
ADIL
Relative Strength Index (RSI) 33.75 40.00
Support Level $3.00 $2.38
Resistance Level $4.07 $4.94
Average True Range (ATR) 0.27 0.42
MACD -0.00 -0.06
Stochastic Oscillator 30.57 31.33

Price Performance

Historical Comparison
QH
ADIL

About QH Quhuo Limited American Depository Shares

Quhuo Ltd is a gig economy platform focusing on local life services in China. It provide tech-enabled, end-to-end operational solutions to consumer service businesses, including on-demand delivery solutions, mobility service solutions, housekeeping and accommodation solutions, and other services. Its three operating segments, include (i) on-demand delivery solutions, (ii) mobility service solutions, and (iii) housekeeping and accommodation solutions and other services. It generates maximum of its revenue from the on-demand delivery solutions segment.

About ADIL Adial Pharmaceuticals Inc

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders.

Share on Social Networks: